1. PEPTIDES AS BIOTHERAPEUTIC TOOLS 2. Intellectual Property OGF and Treatment of Gastrointestinal Cancer Opioid Antagonists and Growth Acceleration Opioid Antagonists and…
Slide 1Janet Woodcock, MD Director, Center for Drug Evaluation and Research Food and Drug Administration Todays Biomedical Innovation: Lost in Translation? QB3 Entrepreneurs…
Slide 1Change Can Happen: New Trends in Clinical Trials in the U.S. Peter Lurie, MD, MPH Health Research Group at Public Citizen Presented at HAI Europe Open Seminar Neues…
Drug Discovery Process - Style1 Your logo Preclinical Studies Clinical Studies Company file Investigational New Drug (IND) application with FDA Phase III: large clinical…
Drug Discovery Process - Style1 Your logo Preclinical Studies Clinical Studies Company file Investigational New Drug (IND) application with FDA Phase III: large clinical…
Drug Discovery Process - Style1 Your logo Preclinical Studies Clinical Studies Company file Investigational New Drug (IND) application with FDA Phase III: large clinical…
Drug Discovery Process - Style1 Your logo Preclinical Studies Clinical Studies Company file Investigational New Drug (IND) application with FDA Phase III: large clinical…
Slide 1Navigating the differences between Investigator- Initiated v. Sponsor-Initiated Clinical Trials – What are the special contract and administration issues to be aware…
Slide 1 Drug Developments in 2010 Implications for the Pharmacy Purchaser Kevin Hoehn PharmD MBA Faxton-St. Luke’s Healthcare Utica NY Slide 2 Annual Growth in Drug Expenditures…